Romney and Ryan’s Medicare plan was unpopular, but toward the end of the race Romney and Obama were nearly running even on healthcare and Medicare issues. Ryan said the GOP ticket lost because of high Democratic turnout, especially in urban areas. The Hill’s story is here.
Speaker Ryan? There’s one thing Ryan definitely hasn’t lost: his standing with conservatives. In a blog post at RedState, conservative commentator Erik Erickson BoehnerJohn BoehnerLast Congress far from ‘do-nothing’ Top aide: Obama worried about impeachment for Syria actions An anti-government ideologue like Mulvaney shouldn't run OMB MORE-with-paul-ryan/" href="http://www.redstate.com/2012/11/13/can-we-replace-john-boehner-with-paul-ryan/">wonders whether the right should ditch Boehner and elect Ryan Speaker, in part because of Boehner’s post-election healthcare statements.
Dolan still fighting: Catholics won't stop fighting the Obama administration's contraception mandate, Cardinal Timothy Dolan reportedly said Tuesday. The Associated Press reported that Dolan, the president of the U.S. Conference of Catholic Bishops, said the church will not comply with the mandate and will continue challenging it in court. Read the Healthwatch story.
Drugs are expensive: Fifty-five drugs accounted for about 85 percent of Medicare’s spending on Part B drugs, the Government Accountability Office said Tuesday. Part B drugs are administered by a doctor, not taken at home, and the class includes some especially costly products as well as some of the most widely used drugs. About 15 million seniors received the flu vaccine in 2010, making it one of the 55 most expensive drugs, while a pair of biological drugs secured their place on the list through a $217,000 per year price tag. The GAO report is here.
The House Energy and Commerce subcommittee on Oversight and Investigations will hold a hearing on the national outbreak of meningitis.
Rep. Edward MarkeyEd MarkeyFive takeaways from Pruitt's EPA hearing Pruitt: Human role in climate change ‘subject to continuing debate’ WHIP LIST: How many Dems will back Sessions? MORE (D-Mass.) will hold a press conference calling for action to strengthen oversight of compounding pharmacies.
State by state
Nevada quietly moves ahead on health law
The Federal Group / Nomir Medical Technologies
The Federal Group / Dental Trade Alliance
What you might have missed on Healthwatch
HHS announces 'innovation fellows'
Ala. governor rejects state exchange, Medicaid expansion
Comments / complaints / suggestions?
Please let us know:
Sam Baker: firstname.lastname@example.org / 202-628-8351
Elise Viebeck: email@example.com / 202-628-8523
Follow us on Twitter @hillhealthwatch